Find your next paid study

M.D. Anderson Cancer CenterNCT04239157

~$75 – $2,000

Actual pay is set by the research site.

LUNG-05: Investigating Chemotherapy Effectiveness for NSCLC Metastatic Patients

This is a Single arm, Simon's two stage pilot study in which patients with Non-Small Cell Lung Cancer (NSCLC) with metastatic disease 2L and beyond will receiv…

NSCLC

University of Illinois at ChicagoNCT06576635

Actual pay is set by the research site.

Effectiveness of 'Cepham Supplement' on Hot Flash Severity/Frequency and Menopausal Symptoms in Postmenopausal Women: A Randomized Double-Blind Placebo-Controlled Trial

The goal of this clinical trial is to learn if a daily nutritional supplement can reduce hot flashes and other menopausal symptoms in postmenopausal women. Th…

D008593

Jacksonville UniversityNCT06939868

Actual pay is set by the research site.

Phase 2

Phase II Clinical Trial Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

This phase II trial test tests how well repurposing atovaquone works in treating patients with platinum-resistant ovarian cancer. Atovaquone is used for the tr…

Ovarian High Grade Serous AdenocarcinomaPlatinum-Resistant Ovarian Carcinoma

Emory UniversityNCT05998135

~$75 – $2,000

Actual pay is set by the research site.

Diabete Type 2Neuropathy, Painful

Combined Circulatory and Dietary Interventions for Neuropathy (CDIN)

The purpose of this study is to evaluate the effectiveness of three different interventions in improving neuropathy symptoms in individuals aged 35-85 with mod…

Loma Linda UniversityNCT07213843

Actual pay is set by the research site.

Phase 2

Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of WAL0921 in Patients With Glomerular Kidney Diseases and Proteinuria

This is an adaptive prospective, multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety, efficacy, pharmacokinetics, and pharm…

Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more

Walden BiosciencesNCT06466135

~$75 – $2,800

Actual pay is set by the research site.

Phase 2

Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response Via Modulation of ANdrogen Receptor (the SPIDERMAN Trial)

The objective of this study is to determine the safety and clinical effects of alternating pharmacologic (i.e. supraphysiologic) testosterone therapy with daro…

Metastatic Castration-resistant Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT07142551

~$75 – $2,000

Actual pay is set by the research site.

Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness at Day 1 and Day 8 Post Op

Phacoemulsification (cataract surgery) is usually performed while temporarily increasing the pressure inside the eye. The purpose of this study is to see if ma…

Cataract

Metrolina Eye Associates, PLLCNCT07222150

~$10 – $1,050

Actual pay is set by the research site.

Phase 3

Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3

This study is being done to answer the question: what is the effect of Vagal Nerve Stimulation (VNS) dosing on opioid withdrawal responses in individuals with …

Withdrawal SymptomsOpioid Use DisorderOpioid Use

Emory UniversityNCT05834478

~$50 – $1,500

Actual pay is set by the research site.

Phase 1

IMetelstat and Azacitidine With or Without Venetoclax GIveN in rElapsed Acute Myeloid Leukemia (IMAGINE Trial)

IMAGINE is a two-part trial to evaluate the safety and preliminary efficacy of imetelstat in combination with azacitidine with or without venetoclax in patient…

Relapsed Acute Myeloid Leukemia

Douglas TremblayNCT07320235

~$150 – $4,500

Actual pay is set by the research site.

Metastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm

Parenting Support Intervention for Families Coping With an Advanced Cancer Diagnosis

This clinical trial examines the acceptability and effect of a parenting support intervention for families coping with solid tumor that has spread to other pla…

M.D. Anderson Cancer CenterNCT05059678

Actual pay is set by the research site.

Phase 1

A Phase 1/2, Multicentre, Open-label Clinical Trial of DT-7012 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Participants With Selected Advanced Solid Tumors (DOMISOL, DOmain_therapeutics Monoclonal antIbody for SOLid Tumors)

This is a phase 1/2, dose-escalation, clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of DT-7012 (an anti-…

Advanced Solid Tumors